92 related articles for article (PubMed ID: 2868700)
1. [Cardiovascular regulation as a function of age. Determinants of antihypertensive treatment based on beta-blockers and calcium inhibitors].
Bühler FR
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():83-90. PubMed ID: 2868700
[TBL] [Abstract][Full Text] [Related]
2. Age and cardiovascular response adaptation. Determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers.
Bühler FR
Hypertension; 1983; 5(5 Pt 2):III94-100. PubMed ID: 6138311
[TBL] [Abstract][Full Text] [Related]
3. Calcium antagonists, firstline partners for betablockers in hypertension.
Bühler FR
Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
[TBL] [Abstract][Full Text] [Related]
4. Management of hypertension. What is the role of beta blockers?
Gifford RW
Postgrad Med; 1988 Feb; Spec No():46-9. PubMed ID: 2894661
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
6. The place of the calcium antagonist verapamil in antihypertensive therapy.
Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
[TBL] [Abstract][Full Text] [Related]
7. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition and calcium channel blockade as primary antihypertensive therapy.
Bühler FR; Müller FB
J Hypertens Suppl; 1986 Dec; 4(5):S435-40. PubMed ID: 3033183
[TBL] [Abstract][Full Text] [Related]
10. Hypertension in elderly--an overview.
Bhattacharyya A; Das P
J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension 2007-2008].
Chatzikyrkou C; Menne J; Haller H
Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
[TBL] [Abstract][Full Text] [Related]
12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of arterial hypertension: 1993 recommendations].
Leeman M
Rev Med Brux; 1994; 15(4):236-40. PubMed ID: 7938996
[TBL] [Abstract][Full Text] [Related]
14. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
15. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
16. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
17. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
18. Effects of antihypertensive therapies on the sympathetic nervous system.
de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
[TBL] [Abstract][Full Text] [Related]
19. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
